Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of CBD Formulations in Healthy Males
NCT06574100Phase 1Recruiting
- Sponsor
- University of Saskatchewan
- Start
- Oct 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cannabidiol in concussion (mTBI) (2 arms), sponsored by University of Saskatchewan. Primary endpoint: Pharmacokinetic Parameters at 4 weeks. Started Oct 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT06574100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574100.